Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ralph Neijenhuis MD

Ralph M. L. Neijenhuis MD

Medical Doctor and PhD Candidate, CAHAL, Center for Congenital Heart Disease Amsterdam-Leiden, Leiden University Medical Center; Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands

Ralph Neijenhuis is a medical doctor and PhD candidate in adult congenital heart disease at the Center for Congenital Heart Disease Amsterdam-Leiden (CAHAL) and the Leiden University Medical Center (LUMC) in the Netherlands. His research focuses on identifying effective treatment strategies for heart failure in adults with congenital heart disease.


Dr. Neijenhuis has received support from the Foundation “De Drie Lichten” (Hilversum, The Netherlands), AstraZeneca, and the Leiden University Medical Center research council Cardio-Vascular cluser Themes for Innovation funding.